Witnessing the stock’s movement on the chart, on March 16, 2023, I-Mab (NASDAQ: IMAB) had a quiet start as it plunged -7.75% to $3.57. During the day, the stock rose to $3.7899 and sunk to $3.54 before settling in for the price of $3.87 at the close. Taking a more long-term approach, IMAB posted a 52-week range of $3.19-$21.44.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -545.60%. This publicly-traded company’s shares outstanding now amounts to $82.11 million, simultaneously with a float of $72.32 million. The organization now has a market capitalization sitting at $299.09 million. At the time of writing, stock’s 50-day Moving Average stood at $5.18, while the 200-day Moving Average is $6.06.
If we measure the efficiency of the company that is accounted for 378 employees. For the Profitability, stocks gross margin was +11.41, operating margin was -2353.06 and Pretax Margin of -2234.35.
I-Mab (IMAB) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. I-Mab’s current insider ownership accounts for 0.75%, in contrast to 50.80% institutional ownership.
I-Mab (IMAB) Earnings and Revenue Records
This company achieved a net margin of -2648.70 while generating a return on equity of -45.88. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
I-Mab’s EPS decrease for this current 12-month fiscal period is -545.60%.
I-Mab (NASDAQ: IMAB) Trading Performance Indicators
Let’s observe the current performance indicators for I-Mab (IMAB). It’s Quick Ratio in the last reported quarter now stands at 7.30. The Stock has managed to achieve an average true range (ATR) of 0.33. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 17.09.
In the same vein, IMAB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.13.
Technical Analysis of I-Mab (IMAB)
Going through the that latest performance of [I-Mab, IMAB]. Its last 5-days volume of 0.35 million was inferior to the volume of 0.51 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 27.15% While, its Average True Range was 0.29.
Raw Stochastic average of I-Mab (IMAB) in the period of the previous 100 days is set at 8.48%, which indicates a major rise in contrast to 3.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 66.79% that was lower than 100.29% volatility it exhibited in the past 100-days period.